FDA Influenced Decision Not to Send Alert on Postvaccination Heart Inflammation: Emails
By Zachary Stieber U.S. drug regulators influenced the decision not to send an alert on heart inflammation cases that were appearing after COVID-19 vaccination, according to emails obtained through the Freedom of Information Act (FOIA). The U.S. Centers for Disease Control and Prevention (CDC) was preparing to issue an alert about postvaccination myocarditis, or heart inflammation…
More Stories
UBS Group Initiates Coverage on Pagaya Technologies (NASDAQ:PGY)
UBS Group initiated coverage on shares of Pagaya Technologies (NASDAQ:PGY – Free Report) in a research note published on Friday...
Ucommune International (NASDAQ:UK) vs. ExlService (NASDAQ:EXLS) Head-To-Head Contrast
Ucommune International (NASDAQ:UK – Get Free Report) and ExlService (NASDAQ:EXLS – Get Free Report) are both finance companies, but which...
Head to Head Review: SBC Medical Group (NASDAQ:SBC) vs. Teladoc Health (NYSE:TDOC)
SBC Medical Group (NASDAQ:SBC – Get Free Report) and Teladoc Health (NYSE:TDOC – Get Free Report) are both small-cap medical...
Financial Analysis: TSS (TSSI) & The Competition
Institutional and Insider Ownership 44.6% of shares of all “Management consulting services” companies are held by institutional investors. 30.5% of...
Comparing Simon Property Group (NYSE:SPG) and Farmland Partners (NYSE:FPI)
Simon Property Group (NYSE:SPG – Get Free Report) and Farmland Partners (NYSE:FPI – Get Free Report) are both finance companies,...
Brokerages Set TPG RE Finance Trust, Inc. (NYSE:TRTX) Price Target at $9.08
TPG RE Finance Trust, Inc. (NYSE:TRTX – Get Free Report) has been assigned an average rating of “Moderate Buy” from...